These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Altered Intrinsic Pyramidal Neuron Properties and Pathway-Specific Synaptic Dysfunction Underlie Aberrant Hippocampal Network Function in a Mouse Model of Tauopathy. Booth CA; Witton J; Nowacki J; Tsaneva-Atanasova K; Jones MW; Randall AD; Brown JT J Neurosci; 2016 Jan; 36(2):350-63. PubMed ID: 26758828 [TBL] [Abstract][Full Text] [Related]
5. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy. Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice. Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665 [TBL] [Abstract][Full Text] [Related]
7. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease. Shao CY; Mirra SS; Sait HB; Sacktor TC; Sigurdsson EM Acta Neuropathol; 2011 Sep; 122(3):285-92. PubMed ID: 21630115 [TBL] [Abstract][Full Text] [Related]
8. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model. Helboe L; Egebjerg J; Barkholt P; Volbracht C Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086 [TBL] [Abstract][Full Text] [Related]
9. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Counts SE; Alldred MJ; Che S; Ginsberg SD; Mufson EJ Neuropharmacology; 2014 Apr; 79():172-9. PubMed ID: 24445080 [TBL] [Abstract][Full Text] [Related]
10. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. Polydoro M; Acker CM; Duff K; Castillo PE; Davies P J Neurosci; 2009 Aug; 29(34):10741-9. PubMed ID: 19710325 [TBL] [Abstract][Full Text] [Related]
11. Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits. Koss DJ; Robinson L; Mietelska-Porowska A; Gasiorowska A; Sepčić K; Turk T; Jaspars M; Niewiadomska G; Scott RH; Platt B; Riedel G Cell Mol Life Sci; 2015 Dec; 72(23):4613-32. PubMed ID: 26070304 [TBL] [Abstract][Full Text] [Related]
12. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model. Lauretti E; Li JG; Di Meco A; Praticò D Transl Psychiatry; 2017 Jan; 7(1):e1020. PubMed ID: 28140402 [TBL] [Abstract][Full Text] [Related]
13. Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD). Alldred MJ; Lee SH; Petkova E; Ginsberg SD Brain Struct Funct; 2015 Sep; 220(5):2983-96. PubMed ID: 25031177 [TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Ginsberg SD; Alldred MJ; Counts SE; Cataldo AM; Neve RL; Jiang Y; Wuu J; Chao MV; Mufson EJ; Nixon RA; Che S Biol Psychiatry; 2010 Nov; 68(10):885-93. PubMed ID: 20655510 [TBL] [Abstract][Full Text] [Related]
15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
16. Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy. Damianich A; Facal CL; Muñiz JA; Mininni C; Soiza-Reilly M; Ponce De León M; Urrutia L; Falasco G; Ferrario JE; Avale ME Brain; 2021 Sep; 144(8):2302-2309. PubMed ID: 34059893 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice. Crescenzi R; DeBrosse C; Nanga RP; Byrne MD; Krishnamoorthy G; D'Aquilla K; Nath H; Morales KH; Iba M; Hariharan H; Lee VM; Detre JA; Reddy R Hippocampus; 2017 Mar; 27(3):285-302. PubMed ID: 27997993 [TBL] [Abstract][Full Text] [Related]
18. Trans-synaptic spread of tau pathology in vivo. Liu L; Drouet V; Wu JW; Witter MP; Small SA; Clelland C; Duff K PLoS One; 2012; 7(2):e31302. PubMed ID: 22312444 [TBL] [Abstract][Full Text] [Related]
19. Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy. Maurin H; Chong SA; Kraev I; Davies H; Kremer A; Seymour CM; Lechat B; Jaworski T; Borghgraef P; Devijver H; Callewaert G; Stewart MG; Van Leuven F PLoS One; 2014; 9(2):e87605. PubMed ID: 24498342 [TBL] [Abstract][Full Text] [Related]
20. Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice. Hoffmann NA; Dorostkar MM; Blumenstock S; Goedert M; Herms J Acta Neuropathol Commun; 2013 Dec; 1():82. PubMed ID: 24344647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]